Showing results (271-280 of 343) with videos related to
Sort By:
Pageof 35
Journal of Autoimmunity|August 5, 2015
Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver diseaseZhaolian Bian, Qi Miao, Wei Zhong, et al.Clinical Reviews in Allergy & Immunology|January 29, 2021
Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature ReviewYou Li, Li Yan, Rui Wang, et al.Gut Microbes|September 25, 2025
Tryptophan catabolites from microbiota ameliorate immune-mediated hepatitis through activating aryl hydrocarbon receptor of T cellsBo Li, Xueying Liang, Yikang Li, et al.Clinical Reviews in Allergy & Immunology|March 30, 2024
Osteoporosis and Primary Biliary Cholangitis: A Trans-ethnic Mendelian Randomization AnalysisYi Wu, Qiwei Qian, Qiaoyan Liu, et al.Hepatology (Baltimore, Md.)|July 28, 2023
Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitisYikang Li, Bo Li, Xiao Xiao, et al.Journal of Hepatology|September 2, 2023
A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasisRuiling Chen, Bingyuan Huang, Min Lian, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 30, 2021
Morphological, Functional, and Tissue Characterization of Silent Myocardial Involvement in Patients With Primary Biliary CholangitisPan Jiang, Zehao Feng, Li Sheng, et al.Gut Microbes|August 26, 2021
Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary CholangitisBo Li, Jun Zhang, Yong Chen, et al.Journal of Autoimmunity|January 15, 2023
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cellsZhuwan Lyu, Bingyuan Huang, Jun Zhang, et al.Journal of Autoimmunity|February 27, 2025
Optimizing the tapering scheme of corticosteroid treatment for acute onset of autoimmune hepatitisRui Wang, Qiuxiang Lin, Li Sheng, et al.Pageof 35